ANGIOGENESIS

metrics 2024

Fostering Innovation in Vascular Biology Research

Introduction

ANGIOGENESIS is a prestigious academic journal published by Springer, focusing on the vital field of angiogenesis research, a cornerstone in understanding tumor biology and tissue regeneration. Established in 1997 and continuously evolving, this journal has solidified its reputation, ranking in the Q1 category for Cancer Research, Clinical Biochemistry, and Physiology as of 2023. With an impressive impact factor, it serves as an essential platform for disseminating cutting-edge research findings, critical reviews, and novel methodologies. ANGIOGENESIS is indexed in high-impact databases and exhibits exceptional Scopus ranks—1st in Clinical Biochemistry, 6th in Physiology, and 14th in Cancer Research, underscoring its significant contribution to the scientific community. Although it does not currently offer open access options, it ensures that all articles maintain rigorous peer-review standards to meet the highest academic excellence. Researchers, professionals, and students alike will find ANGIOGENESIS to be an invaluable resource in advancing their knowledge and research in the intricate mechanisms of vascular biology.

Metrics 2024

SCIMAGO Journal Rank3.29
Journal Impact Factor9.20
Journal Impact Factor (5 years)8.50
H-Index101
Journal IF Without Self9.20
Eigen Factor0.00
Normal Eigen Factor0.91
Influence2.07
Immediacy Index2.40
Cited Half Life6.40
Citing Half Life7.70
JCI2.00
Total Documents1003
WOS Total Citations4735
SCIMAGO Total Citations15487
SCIMAGO SELF Citations497
Scopus Journal Rank3.29
Cites / Document (2 Years)8.13
Cites / Document (3 Years)8.39
Cites / Document (4 Years)7.87

Metrics History

Rank 2024

Scopus

Clinical Biochemistry in Biochemistry, Genetics and Molecular Biology
Rank #1/117
Percentile 99.15
Quartile Q1
Physiology in Biochemistry, Genetics and Molecular Biology
Rank #6/193
Percentile 96.89
Quartile Q1
Cancer Research in Biochemistry, Genetics and Molecular Biology
Rank #14/230
Percentile 93.91
Quartile Q1

IF (Web Of Science)

PERIPHERAL VASCULAR DISEASE
Rank 3/96
Percentile 97.40
Quartile Q1

JCI (Web Of Science)

PERIPHERAL VASCULAR DISEASE
Rank 5/96
Percentile 94.79
Quartile Q1

Quartile History

Similar Journals

Journal of Developmental Biology

Empowering the Future of Developmental Research
Publisher: MDPIISSN: Frequency: 4 issues/year

Journal of Developmental Biology, published by MDPI, is an esteemed open access journal that has been contributing to the field since its inception in 2013. With a focus on developmental processes across various biological systems, this journal serves as a vital platform for disseminating cutting-edge research and fostering dialogue among experts in the fields of Cell Biology, Developmental Biology, and Molecular Biology. The journal currently holds a commendable Q2 ranking in both Developmental Biology and Molecular Biology, underscoring its significance in advancing knowledge within these domains. Operating out of Switzerland, and featuring an engaging array of articles, the journal prioritizes accessibility through its Open Access model, further expanding the reach of vital research findings. Whether you are a seasoned researcher or an enthusiastic student, the Journal of Developmental Biology provides an essential resource for the latest insights and developments in this rapidly evolving field.

INTERNATIONAL ANGIOLOGY

Elevating Cardiovascular Medicine with Cutting-Edge Insights
Publisher: EDIZIONI MINERVA MEDICAISSN: 0392-9590Frequency: 6 issues/year

INTERNATIONAL ANGIOLOGY is a leading journal in the field of Cardiology and Cardiovascular Medicine, published by EDIZIONI MINERVA MEDICA. Since its inception in 1984, it has become an essential resource for researchers, clinicians, and students interested in the latest advancements and research in vascular health. With an ISSN of 0392-9590 and an E-ISSN of 1827-1839, the journal maintains a strong academic presence, reflected by its category quartile ranking of Q3 in 2023, positioning it among the noteworthy publications within the cardiology sector, as indicated by its Scopus rank of #209 out of 387. Although the journal is not open access, it provides a critical platform for disseminating knowledge on topics ranging from angiogenesis to interventional vascular procedures. As the journal continues to evolve towards its convergence in 2024, it remains committed to fostering academic discourse and delivering high-quality research that shapes the future of cardiovascular medicine.

Cell Stem Cell

Elevating Research Standards in Stem Cell and Molecular Biology
Publisher: CELL PRESSISSN: 1934-5909Frequency: 12 issues/year

Cell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.

GENESIS

Igniting Innovation in Cell Biology and Beyond
Publisher: WILEYISSN: 1526-954XFrequency: 12 issues/year

GENESIS is a renowned journal dedicated to advancing the fields of Cell Biology, Endocrinology, Genetics, and Miscellaneous Medicine, published by WILEY. With an ISSN of 1526-954X and an E-ISSN of 1526-968X, this journal has established a significant presence in academic publishing since its inception in 2000. Positioned within the Q3 category for Cell Biology and Q2 categories for Endocrinology, Genetics, and Medicine in the 2023 rankings, GENESIS offers an interdisciplinary platform that fosters pioneering research and innovation. Additionally, the journal provides options for Open Access, ensuring that vital discoveries are accessible to a broader audience. Researchers, professionals, and students alike will find valuable insights and cutting-edge studies within its pages, making GENESIS a crucial resource for anyone invested in the biological sciences.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Fostering Collaboration in Pathology and Molecular Science
Publisher: WILEYISSN: 0959-9673Frequency: 6 issues/year

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

CELL BIOCHEMISTRY AND FUNCTION

Unraveling Cellular Mysteries Through Innovative Research
Publisher: WILEYISSN: 0263-6484Frequency: 8 issues/year

CELL BIOCHEMISTRY AND FUNCTION is a prominent journal dedicated to disseminating high-quality research in the fields of biochemistry, cell biology, and clinical biochemistry. Published by Wiley, this journal has maintained an esteemed reputation since its inception in 1983, bridging decades of scientific advancements and contributions until 2024. With ISSN 0263-6484 and E-ISSN 1099-0844, it serves as a vital resource for researchers, professionals, and students. The journal is classified in quartiles Q2 and Q3 across various categories in the 2023 rankings, showcasing its impact and significance within the academic community. Highlighting essential studies in medicinal biochemistry and cellular functionalities, CELL BIOCHEMISTRY AND FUNCTION not only presents cutting-edge research but also encourages interdisciplinary collaboration, thereby advancing the understanding of biochemical processes that underlie living systems. With no open access currently available, readers are encouraged to access articles through institutional subscriptions or individual purchases, ensuring exclusive engagement with the latest scientific findings in this dynamic field.

Inflammation and Regeneration

Catalyzing innovation in cell biology and regenerative science.
Publisher: BMCISSN: Frequency: 1 issue/year

Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Transforming cardiovascular health through impactful discoveries.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1079-5642Frequency: 12 issues/year

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

BIOESSAYS

Elevating Knowledge in the Life Sciences
Publisher: WILEYISSN: 0265-9247Frequency: 12 issues/year

BIOESSAYS, published by WILEY, is a leading academic journal dedicated to the dynamic fields of biochemistry, genetics, and molecular biology. With an impressive impact factor and recognized as a Q1 journal in its category for 2023, it ranks 49 out of 221 in the Scopus database, placing it within the 78th percentile among its peers. Since its inception in 1984, BIOESSAYS has served as a vital platform for researchers, professionals, and students, facilitating the dissemination of pivotal findings, innovative theories, and review articles that shape the current understanding of biological sciences. Although it does not offer open access, the journal remains key for those seeking to stay at the forefront of scientific discovery and discussion within this ever-evolving discipline. With its commitment to high-quality, peer-reviewed content, BIOESSAYS continues to influence future research directions and academic discourse.

Journal of Biochemistry

Elevating the discourse in biochemistry and molecular biology.
Publisher: OXFORD UNIV PRESSISSN: 0021-924XFrequency: 12 issues/year

Journal of Biochemistry, published by Oxford University Press, is a prestigious academic journal that has been at the forefront of biochemical research since its inception in 1922. With an ISSN of 0021-924X and an E-ISSN of 1756-2651, this journal serves as a platform for disseminating high-quality research in the fields of biochemistry, molecular biology, and medicine, holding impressive rankings such as Q2 in Biochemistry and Medicine (miscellaneous) in 2023. As of 2024, the journal continues to explore significant topics in these areas, offering valuable insights for researchers, professionals, and students alike. The journal does not currently offer open access, but it remains a vital resource for anyone in the biochemical community seeking to stay updated on the latest discoveries and advancements. With its rich history and dedication to scientific excellence, the Journal of Biochemistry is an indispensable part of the scholarly landscape.